News Sentiment

CNMD sentiment intelligence

CONMED Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 65 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 38.48 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+13.7% over one week, +10.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

CONMED (NYSE:CNMD) Downgraded by Zacks Research to Strong Sell

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 13.7% Price confirming higher
Trend fit Trend inactive 10.7% over four weeks
Fair value -41.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 41
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 8
simplywall.st 5
TradingKey 5
MarketBeat 4
Investing.com 4
TradingView 3
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 24
Analyst action 3
Macro sensitivity 2
Capital return 1
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 65
TradingKey Direct company coverage

Conmed Corp (CNMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Conmed Corp (CNMD), detailing its current price momentum score, support and resistance levels. It outlines various technical indicators like MACD, RSI, and moving averages, offering buy, sell, or neutral signals for investment referen

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 08:10
Source
TradingKey
Intellectia AI Direct company coverage

CNMD Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides an overview of Conmed Corp (CNMD)'s financials, detailing its revenue breakdown, profitability margins, and a comparison with competitors. General Surgery is highlighted as the largest revenue contributor, and key financial metrics like gross margin (57.86%)

Tone
Positive 62/100
Event
Earnings
Published
22 Jun 2026 06:39
Source
Intellectia AI
TradingKey Direct company coverage

Conmed Corp (CNMD) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of Conmed Corp (CNMD), indicating a current financial score of 7.93, ranking 50 out of 204 in its industry. The company's financial status is weak, despite high operating efficiency, with recent quarterly revenue decreasing by 1.31

Tone
Negative 34/100
Event
Earnings
Published
18 Jun 2026 05:39
Source
TradingKey
TradingKey Direct company coverage

Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Conmed Corp (CNMD) has an earnings forecast score of 6.00, placing it 172nd in the Healthcare Equipment & Supplies industry. Analysts have an average target price of $52.00 for CNMD, with a "Hold" rating from 6 analysts. The company's expected revenue for the next quarter is $337

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 04:10
Source
TradingKey
TradingView Direct company coverage

CONMED names John E. Gallagher as EVP & CFO, Patrick Beyer steps down as interim PFO

CONMED has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. This appointment will lead to Patrick Beyer and Kimberly Lockwood ceasing their interim financial reporting officer roles. Gallagher, 53, previously served as

Tone
Positive 66/100
Event
Market update
Published
18 Jun 2026 04:03
Source
TradingView
TradingKey Direct company coverage

Conmed Corp (CNMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

Conmed Corp (CNMD) has distributed a total of $96.37 million in dividends over the past five years. The article provides a detailed historical timeline of upcoming and past dividend payouts, including record dates, payment dates, and ex-dividend dates for quarterly cash dividends

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 22:10
Source
TradingKey
Stock Titan Direct company coverage

CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay

CONMED Corporation has appointed John E. Gallagher as Executive Vice President and Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of finance experience, will also serve as principal financial and principal accounting officer. His comp

Tone
Positive 62/100
Event
Market update
Published
17 Jun 2026 21:10
Source
Stock Titan
Investing.com Direct company coverage

Conmed names John Gallagher as CFO effective July 15

CONMED Corporation has announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher brings extensive financial experience from previous roles at Certara, Cue Health Inc., and Becton, Dickinson & Co. He succeeds Todd Garner,

Tone
Positive 62/100
Event
Market update
Published
17 Jun 2026 21:10
Source
Investing.com
TradingKey Direct company coverage

Conmed Corp (CNMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Conmed Corp (CNMD) for the fiscal year 2023. It categorizes revenue by business segments, namely General Surgery and Orthopedic Surgery, and by geographical regions including the United States, Europe & Middle East & Africa,

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 21:10
Source
TradingKey
Stock Titan Direct company coverage

CONMED appoints John Gallagher as CFO, effective July 15 | CNMD Stock News

CONMED Corporation (NYSE: CNMD) announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Gallagher, who brings nearly three decades of financial experience in healthcare and medical technology, succeeds Todd Garner, who will rema

Tone
Positive 73/100
Event
Market update
Published
17 Jun 2026 20:10
Source
Stock Titan
Business Wire Direct company coverage

CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer

CONMED Corporation announced the appointment of John E. Gallagher as its new Chief Financial Officer, effective July 15, 2026. Mr. Gallagher brings extensive financial leadership experience from various healthcare and industrial companies, including previous CFO roles at Certara,

Tone
Positive 71/100
Event
Market update
Published
16 Jun 2026 02:41
Source
Business Wire